Search

Recent Update on the Development of Leucine-Rich Repeat Kinase 2(LRRK2) Inhibitors: A Promising Target for the Treatment of Parkinson’sDisease

Journal: Medicinal Chemistry
Volume: 18 Issue: 7 Year: 2022 Page: 757-771
Author(s):

Progressive Experimental Screening Tools and Techniques for Parkinsons Disease: An Update

Ebook: Animal Models for Neurological Disorders
Volume: 1 Year: 2021
Author(s): Anil Kumar,Monika Kadian,Hemprabha Tainguriya,Nitin Rawat
Doi: 10.2174/9789815039689121010007

Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson’s Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 15 Issue: 10 Year: 2015 Page: 927-938
Author(s): Paul J. Gilligan

Journal: Current Topics in Medicinal Chemistry
Volume: 9 Issue: 1 Year: 2009 Page: 913-948
Author(s): Mario Di Napoli

Mitochondria: Prospective Targets for Neuroprotection in Parkinson's Disease

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 5558-5573
Author(s): Anuradha Yadav, Swati Agarwal, Shashi Kant Tiwari, Rajnish K. Chaturvedi

On the Pathogenesis and Neuroprotective Treatment of Parkinson Disease: What have we Learned from the Genetic Forms of this Disease?

Journal: Current Medicinal Chemistry
Volume: 15 Issue: 2 Year: 2008 Page: 2305-2320
Author(s): M. A. Mena, J. A. Rodriguez-Navarro, R. Ros, J. G. de Yebenes